HLA-B27 Gene Test for Arthritis at Lahore PCR Lab

HLA-B27 Gene at Lahore PCR Lab

The HLA-B27 Gene test is a specialized molecular diagnostic investigation designed to detect the presence of the Human Leukocyte Antigen B27 (HLA-B27) allele on the surface of white blood cells. Human leukocyte antigens are proteins encoded by the major histocompatibility complex (MHC) class I genes located on chromosome 6. These proteins play a fundamental role in the body’s immune system, helping defense cells distinguish between self-proteins and foreign invaders such as bacteria and viruses. However, certain HLA alleles, particularly HLA-B27, are strongly associated with autoimmune disorders and systemic inflammatory conditions, collectively known as seronegative spondyloarthropathies.

At Lahore PCR Lab in Lahore, Pakistan, this test is performed using advanced Polymerase Chain Reaction (PCR) technology. PCR is the gold standard for genetic and molecular testing, offering superior sensitivity and specificity compared to traditional serological methods. By directly amplifying genomic DNA extracted from the patient’s blood sample, the molecular diagnostic team at Lahore PCR Lab can accurately identify the presence or absence of the HLA-B27 gene. This high-precision testing is crucial for clinical decision-making, as it provides definitive genetic data that assists rheumatologists, orthopedists, and general physicians in establishing complex diagnoses.

The clinical importance of the HLA-B27 gene test lies in its strong diagnostic association with several chronic inflammatory joint diseases. While possessing the HLA-B27 gene does not guarantee that an individual will develop an autoimmune disease, its presence significantly increases the statistical risk. Conversely, a negative result can help clinicians rule out HLA-B27-associated conditions in patients presenting with atypical joint pain or spinal stiffness. The primary anatomical structures evaluated indirectly through this genetic marker include the sacroiliac joints, the axial skeleton (spine), peripheral joints, the eyes (specifically the uvea), and the insertion sites of tendons and ligaments (entheses).

The diagnostic value of this molecular test is particularly evident in the early stages of inflammatory diseases, where structural changes may not yet be visible on conventional X-rays or magnetic resonance imaging (MRI). By identifying the genetic predisposition early, healthcare providers can initiate targeted therapeutic interventions, monitor disease progression more closely, and implement lifestyle modifications to preserve joint mobility and patient quality of life. Common indications for ordering this test include chronic lower back pain that worsens with rest, joint pain accompanied by eye inflammation (uveitis), skin lesions (psoriasis), or chronic gastrointestinal symptoms.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure sample integrity and accurate molecular analysis. Because the HLA-B27 test is a genetic assay analyzing genomic DNA, the genetic material itself does not change based on dietary intake or daily activities. However, patients should follow these guidelines to ensure a smooth collection process:

• No Fasting Required: Patients do not need to fast before the test. You may eat and drink normally prior to your appointment at Lahore PCR Lab.
• Medication Disclosure: Inform the laboratory staff and your referring physician about all medications you are currently taking, especially immunosuppressants, biologics, or chemotherapy agents. While these medications do not alter your genetic makeup, they are important for the clinician’s overall diagnostic interpretation.
• Blood Transfusion History: If you have received a blood transfusion within the last three to four months, inform the laboratory. Transfused white blood cells can temporarily interfere with genetic testing results.
• Hydration: Staying well-hydrated makes venipuncture (blood collection) easier and more comfortable by improving vein visibility and blood flow.
• Identification: Bring your official government-issued identification card and the physician’s referral slip to verify your identity and ensure correct test registration.

During the Procedure

The HLA-B27 gene test requires a standard peripheral blood draw. The entire procedure is conducted by highly trained phlebotomists at Lahore PCR Lab, adhering to strict aseptic techniques and international safety standards:

• Patient Positioning: You will be asked to sit comfortably in a specialized blood collection chair. You should extend your arm, resting it on the armrest to expose the inner elbow area (antecubital fossa).
• Vein Selection and Preparation: The phlebotomist will apply a sterile tourniquet a few inches above the elbow to restrict blood flow and make the veins more prominent. The selected site, usually the median cubital vein, is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry.
• Sample Collection: A sterile, single-use needle is gently inserted into the vein. Blood is drawn directly into an EDTA anticoagulated tube (typically a purple-top tube), which prevents the blood from clotting and preserves the white blood cells containing the genomic DNA.
• Duration and Experience: The actual blood draw takes less than two minutes. You may feel a brief, mild pinch as the needle enters the skin. The phlebotomist will remove the tourniquet, gently withdraw the needle, and immediately apply pressure to the puncture site with a sterile cotton ball or gauze.
• Post-Collection Care: An adhesive bandage will be applied over the gauze. You will be advised to keep pressure on the site for a few minutes and avoid lifting heavy objects with that arm for the rest of the day to prevent bruising (hematoma formation).
• Safety and Processing: All materials used during the procedure are disposed of in biohazard containers. The collected sample is labeled with unique barcoded identifiers to prevent any risk of sample mix-up, and it is immediately sent to the molecular diagnostics division of Lahore PCR Lab for DNA extraction and PCR amplification.

When is a HLA-B27 Gene Test Performed?

Suspected Ankylosing Spondylitis

Ankylosing spondylitis (AS) is a chronic, progressive inflammatory arthritis that primarily affects the spine and sacroiliac joints, leading to eventual fusion of the vertebrae (ankylosis). Physicians frequently request the HLA-B27 test when a patient presents with chronic lower back pain that has inflammatory characteristics, such as morning stiffness lasting longer than 30 minutes, improvement of pain with physical activity, and no relief with rest. Because approximately 90% of patients with ankylosing spondylitis carry the HLA-B27 gene, a positive result strongly supports the clinical diagnosis when combined with characteristic symptoms and imaging findings of sacroiliitis.

Evaluation of Reactive Arthritis

Reactive arthritis, formerly known as Reiter’s syndrome, is an inflammatory joint condition that develops in response to an infection in another part of the body, typically the genitourinary tract (caused by Chlamydia trachomatis) or the gastrointestinal tract (caused by Salmonella, Shigella, Yersinia, or Campylobacter). The classic triad of reactive arthritis includes urethritis, conjunctivitis, and asymmetric arthritis. Since a high percentage of patients with severe or chronic reactive arthritis are HLA-B27 positive, physicians utilize this genetic test to help differentiate this condition from other forms of acute arthritis and to assess the likelihood of the disease transitioning into a chronic, long-term arthritic state.

Investigation of Acute Anterior Uveitis

Acute anterior uveitis is a painful inflammation of the middle layer of the eye, specifically the iris and ciliary body. Patients typically present with sudden onset of eye pain, redness, photophobia (sensitivity to light), and blurred vision. Ophthalmologists frequently refer patients for HLA-B27 testing, especially when uveitis is recurrent or bilateral. There is a well-established clinical link between HLA-B27 and isolated anterior uveitis, as well as uveitis associated with systemic spondyloarthropathies. Identifying the HLA-B27 marker helps ophthalmologists coordinate care with rheumatologists to screen for underlying systemic inflammatory diseases.

Diagnosis of Psoriatic Arthritis

Psoriatic arthritis is an inflammatory joint disease that affects some individuals who have psoriasis, a chronic skin condition characterized by red, scaly patches. While psoriatic arthritis is classified as a seronegative spondyloarthropathy, its association with HLA-B27 is particularly strong in patients who present with axial involvement (inflammation of the spine and sacroiliac joints) rather than purely peripheral joint involvement. Physicians request the HLA-B27 gene test in psoriatic patients experiencing spinal stiffness or joint pain to determine if their joint symptoms are genetically linked to the spondyloarthropathy spectrum, which guides the selection of systemic therapies such as biologic agents.

Assessment of Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis (JIA) encompasses several categories of chronic arthritis in children. One specific subtype, enthesitis-related arthritis (ERA), is characterized by joint inflammation combined with enthesitis (inflammation where tendons or ligaments attach to bone). This pediatric condition is closely related to adult spondyloarthropathies and has a strong association with the HLA-B27 gene. Pediatric rheumatologists order the HLA-B27 test in children presenting with lower extremity joint pain, heel pain, or back stiffness to help classify the specific subtype of arthritis, predict the clinical course, and implement early, aggressive treatment strategies to prevent long-term joint damage and growth disturbances.

What Does a HLA-B27 Gene Test Detect?

The HLA-B27 gene test performed at Lahore PCR Lab is designed to detect, analyze, and rule out specific genetic and clinical parameters associated with autoimmune inflammatory conditions. The test clinically evaluates and detects:

• The presence of the HLA-B27 allele within the patient’s genomic DNA.
• The absence of the HLA-B27 allele, helping to lower the probability of HLA-B27-associated spondyloarthropathies.
• Genetic predisposition to Ankylosing Spondylitis in patients presenting with chronic back pain.
• Genetic susceptibility to Reactive Arthritis following gastrointestinal or genitourinary infections.
• A genetic link in patients presenting with recurrent, idiopathic acute anterior uveitis.
• Genetic risk factors for axial involvement in patients diagnosed with Psoriatic Arthritis.
• Predisposition to Enteropathic Arthritis associated with Inflammatory Bowel Disease (Crohn’s disease or Ulcerative Colitis).
• Supportive evidence to differentiate seronegative spondyloarthropathies from Rheumatoid Arthritis (RA), which is typically associated with rheumatoid factor and anti-CCP antibodies.
• Supportive evidence to differentiate inflammatory spinal disease from mechanical lower back pain or degenerative disc disease.
• Genetic markers associated with juvenile enthesitis-related arthritis in pediatric patients.
• The presence of a hereditary risk factor in families with a known history of spondyloarthropathy.
• An explanation for atypical, multi-joint inflammatory symptoms that do not fit classic diagnostic criteria.
• A genetic basis for chronic enthesitis, such as persistent Achilles tendonitis or plantar fasciitis not caused by mechanical strain.
• Risk assessment for the development of extra-articular manifestations, including cardiac conduction abnormalities (aortitis, heart block) associated with HLA-B27.
• Information that assists in clinical trial eligibility for targeted immunotherapies and biologic treatments.
• Baseline genetic data that helps clinicians determine the frequency of clinical follow-ups and imaging studies.
• Confirmation of genetic status in patients with borderline radiographic findings of sacroiliitis.
• A diagnostic piece in the puzzle of undifferentiated spondyloarthropathy, where clinical symptoms are present but do not yet meet full criteria for a specific disease.
• Reassurance for symptomatic patients when a negative result significantly reduces the likelihood of a progressive genetic spinal disease.
• A highly specific molecular sequence, ensuring that cross-reactivity with other HLA alleles (such as HLA-B7 or HLA-B22) is minimized through advanced PCR primers.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, the processing of molecular diagnostic tests is carried out with meticulous attention to detail, quality control, and clinical accuracy. Because the HLA-B27 test utilizes Polymerase Chain Reaction (PCR) technology, the laboratory workflow involves several highly technical stages, including DNA extraction, quality verification of the extracted genetic material, PCR amplification using sequence-specific primers, and post-amplification detection. This sophisticated process ensures that the final result is highly reliable and free from false-positive or false-negative errors.

The standard turnaround time for the HLA-B27 gene test at Lahore PCR Lab is managed efficiently to ensure that patients and their referring physicians receive results promptly. Once the blood sample is collected and registered, it is processed in batches under strict quality-controlled conditions. Patients are provided with an estimated reporting date at the time of sample collection. To enhance patient convenience and streamline healthcare delivery, Lahore PCR Lab offers multiple secure methods for report access. Patients can access their diagnostic reports online through the laboratory’s secure web portal, receive them via email, or collect a printed copy directly from the laboratory facility in Lahore. This digital access ensures that patients can easily share their genetic test results with their treating specialists without unnecessary delays.

HLA-B27 Gene Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HLA-B27 Allele Status	Negative (Absent)	Positive (Present)
Sacroiliac Joints (Clinical Correlation)	Normal joint space, clear margins, no sclerosis or erosion on imaging.	Sacroiliitis, joint space narrowing, subchondral sclerosis, bony erosions, or partial/complete fusion (ankylosis).
Spine and Axial Skeleton (Clinical Correlation)	Normal spinal curvature, preserved vertebral height, flexible spinal mobility.	Squaring of vertebrae, syndesmophyte formation (“bamboo spine”), ligamentous calcification, progressive spinal rigidity.
Ocular Structures (Clinical Correlation)	Clear cornea, quiet anterior chamber, normal pupillary light reflex, no intraocular inflammation.	Anterior uveitis, ciliary flush, inflammatory cells and flare in the anterior chamber, posterior synechiae (iris adhering to lens).
Entheses (Tendon/Ligament Insertions)	No localized tenderness, normal tendon thickness, no inflammatory changes.	Enthesitis, Achilles tendon thickening, plantar fascial inflammation, retrocalcaneal bursitis, localized bone spurs.
Peripheral Joints (Clinical Correlation)	Normal joint space, intact cartilage, no synovial hypertrophy or joint effusion.	Asymmetric oligoarthritis, synovitis, joint effusion, dactylitis (“sausage digits”) in fingers or toes.
Systemic Inflammatory Markers	ESR and CRP within normal physiological reference ranges.	Elevated Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) during active inflammatory phases.
Gastrointestinal Tract (Clinical Correlation)	Normal bowel habits, healthy mucosal lining without chronic inflammation.	Inflammatory bowel disease (Crohn’s disease or Ulcerative Colitis) associated with enteropathic arthritis.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for HLA-B27 Gene?

• Experienced Healthcare Professionals: The laboratory is staffed by highly qualified molecular biologists, pathologists, and laboratory technicians specializing in genetic diagnostics.
• Patient-Focused Care: Lahore PCR Lab prioritizes patient comfort, offering a welcoming environment and professional phlebotomy services to minimize anxiety during blood collection.
• Quality Diagnostic Services: The facility adheres to rigorous internal and external quality control protocols to ensure the highest standards of diagnostic accuracy.
• Professional Reporting: Reports are generated with clear, comprehensive clinical details, making it easy for referring physicians to interpret the genetic data.
• Modern Diagnostic Approach: Utilizing state-of-the-art PCR technology, the lab ensures precise detection of the HLA-B27 allele without cross-reactivity issues.
• Comfortable Environment: The collection centers are designed to be clean, hygienic, and comfortable for patients of all ages, including pediatric and elderly individuals.
• Convenient Location: Situated accessibly within Lahore, Pakistan, the laboratory is easily reachable for patients from all parts of the city and surrounding areas.
• Commitment to Accurate Diagnosis: Lahore PCR Lab is dedicated to providing reliable molecular insights that form the foundation of effective clinical treatment plans.